title: [Bleomycin induced flagellate erythema].
abstract: Bleomycin is an antibiotic with antineoplastic pro prieties. It is used in the traitement of many syndromes. The cutaneous toxicity of bleomycin includes many alteration. We report a case of flagellate erythema following the administration of bleomycin in a 57-year-old women with Kaposi sarcoma. She developped linear lesions 6 days after the first dose of bleomycin. Flagellate erythema is a specific reaction to bleomycin therapy wich occurs in susceptible individuals independently of dose, route of administration and type of malignant disease treated. Its occurs in 10 to 35% of the treated patients.
authors.affiliation: Service de Dermatologie CHU H. Chaker, Sfax, Tunisie.
authors.forename: M
authors.initials: M
authors.lastname: Mseddi
authors.forename: H
authors.initials: H
authors.lastname: Hadj Taieb
authors.forename: W
authors.initials: W
authors.lastname: Abdelmaksoud
authors.forename: M
authors.initials: M
authors.lastname: Khemakhem
authors.forename: H
authors.initials: H
authors.lastname: Turki
authors.forename: A
authors.initials: A
authors.lastname: Masmoudi
authors.forename: A
authors.initials: A
authors.lastname: Zahaf
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects*; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012514:Sarcoma, Kaposi / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D001761:Bleomycin